114 related articles for article (PubMed ID: 16434368)
1. Pure infradiaphragmatic Hodgkin's lymphoma. Clinical features, prognostic factor and comparison with supradiaphragmatic disease.
Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Konstantinou N; Symeonidis A; Karmiris T; Repoussis P; Roussou P; Dimopoulos AM; Kokoris SI; Dimitriadou EM; Kyrtsonis MC; Dimopoulou MN; Tsatalas C; Kokkinis G; Vrakidou E; Grigoraki V; Poziopoulos C; Stamatellou M; Liapis D; Georgiou G; Panayiotidis P; Pangalis GA;
Haematologica; 2006 Jan; 91(1):32-9. PubMed ID: 16434368
[TBL] [Abstract][Full Text] [Related]
2. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.
Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Karkantaris C; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Pizzolo G; Pangalis GA
Haematologica; 2002 Jul; 87(7):701-8; discussion 708. PubMed ID: 12091120
[TBL] [Abstract][Full Text] [Related]
4. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
5. Infradiaphragmatic Hodgkin's disease.
Illés A; Vadász G; Bányai A; Szegedi G
Haematologia (Budap); 1997; 28(3):117-22. PubMed ID: 9283911
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.
Nogová L; Reineke T; Brillant C; Sieniawski M; Rüdiger T; Josting A; Bredenfeld H; Skripnitchenko R; Müller RP; Müller-Hermelink HK; Diehl V; Engert A;
J Clin Oncol; 2008 Jan; 26(3):434-9. PubMed ID: 18086799
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin's lymphoma--long-term outcome: an experience from a tertiary care cancer center in North India.
Ganesan P; Kumar L; Raina V; Sharma A; Bakhshi S; Sreenivas V; Vijayaraghavan M; Thulkar S
Ann Hematol; 2011 Oct; 90(10):1153-60. PubMed ID: 21625999
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma.
Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Rassidakis GZ; Doussis-Anagnostopoulou IA; Hatzioannou M; Vaiopoulos G; Kittas C; Sarris AH; Pizzolo G; Pangalis GA
Haematologica; 2001 Mar; 86(3):274-81. PubMed ID: 11255274
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group.
Engert A; Ballova V; Haverkamp H; Pfistner B; Josting A; Dühmke E; Müller-Hermelink K; Diehl V;
J Clin Oncol; 2005 Aug; 23(22):5052-60. PubMed ID: 15955904
[TBL] [Abstract][Full Text] [Related]
11. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G
Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741
[TBL] [Abstract][Full Text] [Related]
12. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL).
Iannitto E; Accurso V; Federico M; Vallisa D; Pieresca C; Gravina SF; Di Costanzo F; Di Trapani R; Silingardi V; Mariani G
Haematologica; 1997; 82(6):676-82. PubMed ID: 9499666
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic implications of the peculiar clinical characteristics of Hodgkin's disease in clinical stages I-II with isolated neck presentation].
Magrini SM; Cellai E; Papi MG; Pertici M; Lastrucci L; Ponticelli P; Sulprizio S; Biti G
Radiol Med; 1995; 90(1-2):108-12. PubMed ID: 7569074
[TBL] [Abstract][Full Text] [Related]
18. Clinical data and therapeutic approach in elderly patients with Hodgkin's disease.
Bosi A; Ponticelli P; Casini C; Messori A; Bellesi G; Biti G; Cionini L; Longo G; Mungai V; Rossi Ferrini P
Haematologica; 1989; 74(5):463-73. PubMed ID: 2511116
[TBL] [Abstract][Full Text] [Related]
19. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I
Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
[TBL] [Abstract][Full Text] [Related]
20. Long-term (15 years) results of extended field radiotherapy in Hodgkin's disease.
Sevcíková EL; Boljesíková E; Chorváth M; Kovacicová G
Neoplasma; 2000; 47(4):253-6. PubMed ID: 11043832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
